BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, May 25, 2026
Breaking News: Ongoing coverage of the Ebola outbreakBreaking News: Ongoing coverage of the Ebola outbreak
Home » Topics » BioWorld

BioWorld
BioWorld RSS Feed RSS

Pharma USA: Innovators, but architects, too; access is key

March 16, 2026
No Comments
A preview of the next edition of BioWorld, March 16, 2026
Read More

Biggest gainers and losers for March 9-13, 2026

March 16, 2026
The top 10 biopharma stock gainers and losers for the week.
Read More

ICYMI: Week in review, March 9-13, 2026

March 16, 2026
A quick look back at top stories.
Read More
A simulated cell in the early stages of division.
Drug design, drug delivery & technologies

Digital model simulates the first fully functioning living cell

March 16, 2026
By Mar de Miguel
No Comments
Entering a cell and watching its entire inner machinery at work, how DNA is copied, how proteins are assembled, or how it splits in two, has been, for decades, an impossible dream. Now, scientists at the University of Illinois have recreated everything that happens inside a cell at molecular scale in an unprecedented computational model. Syn3A is the first 4D digital cell, capable of combining time and space to simultaneously represent all the internal processes that drive the life cycle of a minimal prokaryotic organism.
Read More

Biopharma money raised: Jan. 1-March 13, 2026

March 13, 2026
Year-to-date money raised in public, private and other financings of biopharma companies.
Read More

Money raised by biopharma

March 13, 2026
Total raised in public, private and other financings of biopharma companies, comparing 2019-2026.
Read More

Regulatory actions for March 13, 2026

March 13, 2026
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Atara, Johnson & Johnson, Pierre, Toro, Ultragreen, Xspray.
Read More

Other news to note for March 13, 2026

March 13, 2026
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Biomarin, Beaubrain, C2N, Circle, Eli Lilly, Enodia, Gyre, Kezar, Trinity, Zuellig.
Read More

In the clinic for March 13, 2026

March 13, 2026
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Bridgebio, Capricor, Insulet, Intensity, Noah, Otsuka, Personalis, Prelude, Regenxbio, Solid, United.
Read More

Financings for March 13, 2026

March 13, 2026
Biopharma and med-tech companies raising money in public or private financings, including: Combat Medical, Monteris, Valanx, Verano.
Read More
Previous 1 2 … 71 72 73 74 75 76 77 78 79 … 9105 9106 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 22, 2026.
  • Brain and DNA

    Sangamo presents primate data for prion suppressor ST-506

    BioWorld Science
    Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
  • TREM2 agonists detailed in Pfizer patent

    BioWorld Science
    Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
  • Red dart and target against blue sky

    Unmasking the X: EPAC2 shifts the fragile X landscape

    BioWorld
    Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
  • Skin irritation on hands

    Recludix presents STAT1/3 inhibitors for dermatological diseases

    BioWorld Science
    Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing